1. Home
  2. EPIX vs GMHS Comparison

EPIX vs GMHS Comparison

Compare EPIX & GMHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • GMHS
  • Stock Information
  • Founded
  • EPIX 2009
  • GMHS N/A
  • Country
  • EPIX Canada
  • GMHS China
  • Employees
  • EPIX N/A
  • GMHS N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • GMHS
  • Sector
  • EPIX Health Care
  • GMHS
  • Exchange
  • EPIX Nasdaq
  • GMHS NYSE
  • Market Cap
  • EPIX 75.9M
  • GMHS 85.7M
  • IPO Year
  • EPIX N/A
  • GMHS N/A
  • Fundamental
  • Price
  • EPIX $1.72
  • GMHS $1.59
  • Analyst Decision
  • EPIX Hold
  • GMHS
  • Analyst Count
  • EPIX 3
  • GMHS 0
  • Target Price
  • EPIX $2.00
  • GMHS N/A
  • AVG Volume (30 Days)
  • EPIX 68.7K
  • GMHS 24.2K
  • Earning Date
  • EPIX 08-04-2025
  • GMHS 01-01-0001
  • Dividend Yield
  • EPIX N/A
  • GMHS N/A
  • EPS Growth
  • EPIX N/A
  • GMHS N/A
  • EPS
  • EPIX N/A
  • GMHS 0.03
  • Revenue
  • EPIX N/A
  • GMHS $119,023,021.00
  • Revenue This Year
  • EPIX N/A
  • GMHS N/A
  • Revenue Next Year
  • EPIX N/A
  • GMHS N/A
  • P/E Ratio
  • EPIX N/A
  • GMHS $56.53
  • Revenue Growth
  • EPIX N/A
  • GMHS N/A
  • 52 Week Low
  • EPIX $1.40
  • GMHS $0.96
  • 52 Week High
  • EPIX $7.88
  • GMHS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 55.34
  • GMHS N/A
  • Support Level
  • EPIX $1.60
  • GMHS N/A
  • Resistance Level
  • EPIX $1.73
  • GMHS N/A
  • Average True Range (ATR)
  • EPIX 0.04
  • GMHS 0.00
  • MACD
  • EPIX 0.00
  • GMHS 0.00
  • Stochastic Oscillator
  • EPIX 76.50
  • GMHS 0.00

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About GMHS GAMEHAUS HOLDINGS INC

Gamehaus Holdings Inc is a technology-driven mobile game publishing company for small- and medium-sized game developers. It built a diverse game portfolio across multiple genres, including social casino, match, simulation, RPG, puzzle, and bingo, others, and distributes mobile games created by developer partners across a wide range of gaming markets, including in countries such as the U.S., the U.K., Australia, Germany, France, Canada, Brazil, Japan, and India, among others. The company offers a comprehensive package of services covering all aspects of the game life cycle, including (i) game development, (ii) screening and pre-publication testing, (iii) user acquisition, and (iv) monetization.

Share on Social Networks: